SERIES A COMMON STOCK PURCHASE WARRANT ENDRA LIFE SCIENCES INC.Warrant Agreement • May 10th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 10th, 2024 Company Industry JurisdictionTHIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, including the prior receipt of Shareholder Approval as set forth in Section 3(i) at any time on or after the Shareholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five-year anniversary of the Initial Exercise Date, provided that if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Sectio
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 10th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 10th, 2024 Company Industry Jurisdiction
SERIES B COMMON STOCK PURCHASE WARRANT ENDRA LIFE SCIENCES INC.Series B Common Stock Purchase Warrant • May 10th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 10th, 2024 Company Industry JurisdictionTHIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, including the prior receipt of Shareholder Approval as set forth in Section 3(i) at any time on or after the Shareholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the twelve month anniversary of the Initial Exercise Date, provided that if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Sec
PLACEMENT AGENT’S COMMON STOCK PURCHASE WARRANT ENDRA LIFE SCIENCES INC.Placement Agent's Common Stock Purchase Warrant • May 10th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 10th, 2024 Company Industry JurisdictionTHIS PLACEMENT AGENT’S COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the _____1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
LOCK-UP AGREEMENTLock-Up Agreement • May 10th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus
Contract Type FiledMay 10th, 2024 Company IndustryRe: Placement Agency Agreement, dated as of ___________, 2024 (the “Placement Agency Agreement”), by and between ENDRA Life Sciences Inc. (the “Company”) and Craig-Hallum Capital Group LLC (the “Placement Agent”)